Published in
Oxford University Press, Clinical Infectious Diseases, 12(71), p. 3226-3228, 2020
DOI: 10.1093/cid/ciaa584
Links
Tools
Impact of community treatment with ivermectin for the control of scabies on the prevalence of antibodies to Strongyloides stercoralis in children
Journal article published in 2020 by
Michael Marks 
,
Sarah Gwyn,
Hilary Toloka,
Christian Kositz,
James Asugeni,
Rowena Asugeni,
Jason Diau,
Kaldor Jm,
John M. Kaldor,
Lucia Romani,
Michelle Redman-Maclaren,
David MacLaren,
Solomon Aw,
Anthony W. Solomon,
Mabey Dc
and other authors.
,
Sarah Gwyn,
Hilary Toloka,
Christian Kositz,
James Asugeni,
Rowena Asugeni,
Jason Diau,
Kaldor Jm,
John M. Kaldor,
Lucia Romani,
Michelle Redman-Maclaren,
David MacLaren,
Solomon Aw,
Anthony W. Solomon,
Mabey Dc
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 
Abstract
Abstract The prevalence of antibodies to Strongyloides stercoralis was measured in 0–12-year-olds using a bead-based immunoassay before and after ivermectin mass drug administration (MDA) for scabies in the Solomon Islands. Seroprevalence was 9.3% before and 5.1% after MDA (P = .019), demonstrating collateral benefits of ivermectin MDA in this setting.